MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

Recruiting now

Conditions studied: Metastatic Colorectal Cancer

In brief

The goal of this study is to investigate the value of MR elastography-based SII as a means of detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct measure of tumor-liver adhesion to investigate the relationship between imaging findings and pathophysiological changes in the Liver.

Key facts

Study ID

NCT06208397

Run by

Shengjing Hospital

People needed

50

Starts

2023-12-24

Expected to finish

2026-12-24

Last updated by the study team

2025-05-15

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosed CRLM
• Pathologic results obtained in surgical patients
• No contraindications for magnetic resonance imaging examination

You may not qualify if…

• Image quality does not meet the measurement requirements.
• the diameter of CRLM <1cm
• Combined with other important organ dysfunction
• Combined with malignant tumor
• Patients who do not sign an informed consent
• Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who cannot remove dentures, insulin pumps, or contraceptive rings)

Where it is running

• Shengjing Hospital of China Medical University — Shenyang, Liaoning, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.